Trial Profile
Comparing the mobilization of patients more than 100 kg who received capped doses with historical control patients who received full uncapped doses
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 21 Sep 2018 New trial record